Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
68,599
Sort by:
Myocardial Infarction - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Myocardial Infarction (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Infarction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
385 pages
Peritoneal Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Peritoneal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Peritoneal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
1845 pages
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Graft Versus Host Disease (GVHD) (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Graft Versus Host Disease (GVHD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
770 pages
Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chemotherapy Induced Peripheral Neuropathy (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Peripheral Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
162 pages
Gastric Ulcers - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Gastric Ulcers (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Gastric Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
57 pages
Pancreatitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Pancreatitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Pancreatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
106 pages
Premature Labor (Tocolysis) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Premature Labor (Tocolysis) (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Premature Labor (Tocolysis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
53 pages
Rhabdomyosarcoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Rhabdomyosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rhabdomyosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
524 pages
Pyelonephritis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Pyelonephritis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pyelonephritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
150 pages
Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Post-Polycythemia Vera Myelofibrosis (PPV-MF) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Post-Polycythemia Vera Myelofibrosis (PPV-MF) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
462 pages
Schistosomiasis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Schistosomiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Schistosomiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
38 pages
Anesthetic Effect - Pipeline Review, H2 2020
US$ 2,000.00
... . The Anesthetic Effect (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Anesthetic Effect and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
104 pages
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Human Papillomavirus (HPV) Associated Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
386 pages
Male Infertility - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Male Infertility (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Male Infertility and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
38 pages
Retinopathy Of Prematurity - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Retinopathy Of Prematurity (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Retinopathy Of Prematurity and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
68 pages
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Proliferative Diabetic Retinopathy (PDR) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
57 pages
Rhinovirus Infections - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Rhinovirus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rhinovirus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
57 pages
Women Infertility - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Women Infertility (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Women Infertility and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
232 pages
Uveitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Uveitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Uveitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
266 pages
Axillary Hyperhidrosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Axillary Hyperhidrosis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Axillary Hyperhidrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
59 pages
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2020
US$ 2,000.00
... . The Female Hypoactive Sexual Desire Disorder (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Female Hypoactive Sexual Desire Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
56 pages
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2020
US$ 2,000.00
... . The Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Paroxysmal Nocturnal Hemoglobinuria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
140 pages
Arterial Thrombosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Arterial Thrombosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arterial Thrombosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
40 pages
Contact Dermatitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Contact Dermatitis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Contact Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
47 pages
Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Leber Congenital Amaurosis (LCA) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Leber Congenital Amaurosis (LCA) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
80 pages
Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Neuromyelitis Optica (Devic’s Syndrome) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Neuromyelitis Optica (Devic’s Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
September 2020
163 pages
Uveal Melanoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Uveal Melanoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Uveal Melanoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
331 pages
Alcoholic Hepatitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Alcoholic Hepatitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Alcoholic Hepatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
103 pages
Hand, Foot and Mouth Disease - Pipeline Review, H2 2020
US$ 2,000.00
... . The Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hand, Foot and Mouth Disease and features dormant and discontinued projects. The guide covers therapeutics under Development ...
September 2020
43 pages
Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Resistant Pseudomonas aeruginosa Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Resistant Pseudomonas aeruginosa Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
57 pages
Liver Transplant Rejection - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Liver Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Liver Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
73 pages
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lassa Fever (Lassa Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
70 pages
Achondroplasia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Achondroplasia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Achondroplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
66 pages
Automated Liquid Handling Market By Type (Standalone, Individual Benchtop Workstation, Multi-Instrument System, and Others), Modality (Fixed Tips and Disposable Tips), Procedure (PCR-Set-Up, Serial Dilution, High-Throughput Screening, Cell Culture, Whole Genome Amplification, Plate Reformatting, Array Printing, and Other Procedures), End User (Biotechnology & Pharmaceutical Companies, Contract Research Organizations, and Academic & Government Research institutes): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,769.00
... high throughput analysis is crucial in such processes. Automated liquid handling offers high throughput processing at the expense of ... hamper the market growth. Furthermore, untapped potential of emerging markets provides lucrative opportunities to the market players. The automated liquid handling market is ...
September 2020
282 pages
Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Cancer Anorexia-Cachexia Syndrome (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Cancer Anorexia-Cachexia Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
102 pages
Drug Overdose - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Drug Overdose (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Drug Overdose and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
79 pages
Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Epstein-Barr Virus (HHV-4) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
209 pages
Hypopharyngeal Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hypopharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hypopharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
495 pages
Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H1N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
270 pages
Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H5N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
192 pages
Influenzavirus B Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Influenzavirus B Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenzavirus B Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
182 pages
Malignant Pleural Effusion - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Malignant Pleural Effusion (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Malignant Pleural Effusion and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
50 pages
Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Marburgvirus Infections (Marburg Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Marburgvirus Infections (Marburg Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
September 2020
112 pages
Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Pseudomonas aeruginosa Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
35 pages
Heavy Metal Poisoning - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Heavy Metal Poisoning (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Heavy Metal Poisoning and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
36 pages
Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline Review, H2 2020
US$ 2,000.00
... Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
September 2020
119 pages
Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product Type (Software and Device), and Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 6,168.00
... the players operating in this market. The global digital therapeutics market is segmented into application, product, sales channel, and region. Based on application, the market is divided into diabetes ...
September 2020
280 pages
5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020
US$ 3,500.00
5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020'; 5-Hydroxytryptamine Receptor...
September 2020
49 pages
